We are Allarta – a regenerative medicine company with platform technology for allogeneic cell therapies.
Built on 30+ years of foundational expertise, Allarta’s proprietary platform is designed to overcome immune rejection, prevent cell escape and safely deliver cell and stem cell therapies.
Our lead product is a cell therapy focused on type 1 diabetes (T1D) as a first indication.
Allarta Life Science was co-founded in 2019 by Dr. Harald Stover, one of the world’s leading researchers in polymers and polymer hydrogels, and Maria Antonakos.
Harald Stover, PhD
Founder and CEO
Maria Antonakos, MBA
Founder and COO